NO983719L - Neovaskularisasjonsinhibitor - Google Patents

Neovaskularisasjonsinhibitor

Info

Publication number
NO983719L
NO983719L NO983719A NO983719A NO983719L NO 983719 L NO983719 L NO 983719L NO 983719 A NO983719 A NO 983719A NO 983719 A NO983719 A NO 983719A NO 983719 L NO983719 L NO 983719L
Authority
NO
Norway
Prior art keywords
neovaskularisasjonsinhibitor
Prior art date
Application number
NO983719A
Other languages
English (en)
Norwegian (no)
Other versions
NO983719D0 (no
Inventor
Masayuki Isaji
Hiroshi Miyata
Yukiyoshi Ajisawa
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO983719D0 publication Critical patent/NO983719D0/no
Publication of NO983719L publication Critical patent/NO983719L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO983719A 1996-02-15 1998-08-13 Neovaskularisasjonsinhibitor NO983719L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6509496 1996-02-15
PCT/JP1997/000354 WO1997029744A1 (fr) 1996-02-15 1997-02-12 Inhibiteur de la neoformation de vaisseaux sanguins

Publications (2)

Publication Number Publication Date
NO983719D0 NO983719D0 (no) 1998-08-13
NO983719L true NO983719L (no) 1998-10-14

Family

ID=13277001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983719A NO983719L (no) 1996-02-15 1998-08-13 Neovaskularisasjonsinhibitor

Country Status (11)

Country Link
US (1) US6407139B1 (fr)
EP (1) EP0894496A4 (fr)
KR (1) KR19990082523A (fr)
CN (1) CN1211182A (fr)
BR (1) BR9707514A (fr)
CA (1) CA2246418A1 (fr)
CZ (1) CZ258598A3 (fr)
EA (1) EA199800721A1 (fr)
NO (1) NO983719L (fr)
NZ (1) NZ331339A (fr)
WO (1) WO1997029744A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100509421B1 (ko) * 1996-09-28 2005-08-22 깃세이 야쿠힌 고교 가부시키가이샤 각막 상피하 혼탁 억제제
EA001745B1 (ru) * 1996-10-14 2001-08-27 Киссеи Фармасьютикал Ко., Лтд. Ингибитор вторичной катаракты
IL132391A0 (en) * 1997-04-18 2001-03-19 Kissei Pharmaceutical Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells
EP1193246A4 (fr) 1999-07-01 2003-05-14 Taisho Pharmaceutical Co Ltd Derives d'acide aminobenzoique
EP1229010A1 (fr) * 1999-10-01 2002-08-07 Japan Energy Corporation Nouveaux derives de diarylamide et utilisation de ces composes comme medicaments
US7531575B2 (en) * 2002-10-31 2009-05-12 Eberhard-Karls-Universität Tübingin Method of modulating cellular activity and agents useful for same
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
US20080009519A1 (en) * 2004-11-17 2008-01-10 Lawrence Steinman Method of modulating t cell functioning
WO2006053390A1 (fr) * 2004-11-17 2006-05-26 Angiogen Pharmaceuticals Pty. Ltd. Procédé de modulation du fonctionnement des cellules b
WO2006122353A1 (fr) * 2005-05-16 2006-11-23 Angiogen Pharmaceuticals Pty. Ltd. Procedes et compositions destines au traitement de la douleur
MX352516B (es) 2006-07-05 2017-04-06 Fibrotech Therapeutics Pty Ltd Compuestos terapeuticos.
JP2008247789A (ja) * 2007-03-30 2008-10-16 Kissei Pharmaceut Co Ltd クローン病に伴う腸管狭窄の進展抑制用医薬組成物
US20090143388A1 (en) * 2007-08-29 2009-06-04 Mohanakumar Kochupurackal Para Treatment of brain disorders
CA2709937C (fr) 2007-12-21 2016-03-22 Fibrotech Therapeutics Pty Ltd Analogues halogenes d'agents antifibrotiques
WO2010137681A1 (fr) * 2009-05-29 2010-12-02 参天製薬株式会社 Agent prophylactique ou thérapeutique pour maladies rétiniennes comprenant du tranilast, méthode de prévention ou de traitement de maladies rétiniennes, tranilast ou sel pharmaceutiquement acceptable de celui-ci, et utilisation de ceux-ci
ES2474765T3 (es) 2009-06-17 2014-07-09 National University Corporation Kumamoto University Agente profiláctico y/o terapéutico para la dismenorrea
CN102574843B (zh) 2009-10-22 2015-06-17 法博太科制药有限公司 抗纤维化剂的稠环类似物
SI2642989T1 (sl) * 2010-11-24 2019-07-31 Occurx Pty Ltd Metode zdravljenja očesnih bolezni povezanih z vnetjem in vaskularno proliferacijo
CN102657647A (zh) * 2012-04-06 2012-09-12 澳门大学 Ic-4在抗血管新生中的应用
EP3577103A1 (fr) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd. Composés anti-fibrotiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163222A (ja) * 1991-12-18 1993-06-29 Kissei Pharmaceut Co Ltd コラーゲン過剰合成疾患治療剤
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5512591A (en) * 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
EP1181904B1 (fr) * 1994-10-17 2009-06-24 Kabushikikaisha Igaki Iryo Sekkei Stent pour liberér un médicament
DE59606488D1 (de) * 1995-08-31 2001-04-05 Infineon Technologies Ag Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
ATE222759T1 (de) * 1996-02-07 2002-09-15 Lead Chem Co Ltd Tranilast enthaltendes externum und verfahren zu dessen herstellung

Also Published As

Publication number Publication date
CA2246418A1 (fr) 1997-08-21
NO983719D0 (no) 1998-08-13
EP0894496A1 (fr) 1999-02-03
US6407139B1 (en) 2002-06-18
BR9707514A (pt) 1999-07-27
EA199800721A1 (ru) 1999-02-25
CN1211182A (zh) 1999-03-17
EP0894496A4 (fr) 2001-01-03
NZ331339A (en) 2001-02-23
CZ258598A3 (cs) 1998-11-11
KR19990082523A (ko) 1999-11-25
WO1997029744A1 (fr) 1997-08-21

Similar Documents

Publication Publication Date Title
DE69712689D1 (de) Prüfpunktrechnersystem
ATE208395T1 (de) Thiophenopyrimidine
BR9704464A (pt) Evisceradora
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
DE69709668D1 (de) Viskositätsindexverbesserungsdispergiermittel
NO985865L (no) Lager-bµreanordning
NO983719D0 (no) Neovaskularisasjonsinhibitor
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
DE59609702D1 (de) Pulversprüheinrichtung
BR9707467A (pt) 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas
DE59706319D1 (de) Carbamoylcarbonsäureamidoxime
BR9708716A (pt) 3-cianoaril-pirazóis
ATE267568T1 (de) Epithese
DE59610630D1 (de) Paradontalsonde
FI2497U1 (fi) Puuliitos
BR9602174A (pt) Lecton massoterapeutico
BR9603698A (pt) Hidro-escova dorso-lombar
BR7601508U (pt) Cogafa
BR9603976A (pt) Stop-entope
BR7601419U (pt) Mourao
BR7601310U (pt) Microlivro
BR7600030U (pt) Cinturita
BR7600429U (pt) Hidrolax
BR9603977A (pt) Fix-ped

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application